The first quantitative histomorphological analyses of bone vitality and inflammation in surgical specimens of patients with medication-related osteonecrosis of the jaw

被引:4
|
作者
Mamilos, Andreas [1 ]
Spoerl, Steffen [2 ]
Spanier, Gerrit [2 ]
Ettl, Tobias [2 ]
Brochhausen, Christoph [1 ]
Klingelhoeffer, Christoph [2 ]
机构
[1] Univ Regensburg, Dept Pathol, Regensburg, Germany
[2] Univ Hosp Regensburg, Dept Craniomaxillofacial Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany
关键词
histopathology; inflammation; regeneration; medication-related osteonecrosis of the jaw; surgery; BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; RISK-FACTORS; MANAGEMENT; CANCER; DENOSUMAB;
D O I
10.1111/jop.13112
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background The purpose of the study was to categorize the vitality and inflammation of resected bone of patients with medication-related osteonecrosis of the jaw (MRONJ) and to correlate the grade of inflammation with the surgical success. Methods This prospective study includes 44 patients with stage III MRONJ. Necrotic bone was resected in a block fashioned way. After demineralization and staining, histological analyses were performed by measuring the areas of necrotic, vital, and regenerative bone. Areas of chronic and acute inflammation were categorized as non, mild, moderate, and severe and were correlated with surgical success and parameters of inflammation in blood plasma (C-reactive protein and leukocytes). Results An average area of 59.0% was necrotic in the examined specimen. Vital bone was measured with an average area of 40.9%. The stage of chronic inflammation correlated with the amount of vital bone (P < .001) and the success of surgery (P = .002). If acute inflammation was dominant, chronic inflammation areas were found less while necrotic areas were observed more (P < .001). Also, the risk of relapses, wound healing disorders, and the level of C-reactive protein were elevated if acute inflammation was severe or moderate (P = .031). Areas of bone regeneration were seen only in 11.3% of vital bone areas and occurred independently of infection stages. Conclusion If possible, surgery should be delayed in patients with signs of severe acute inflammation. Patients may profit from prolonged pre-operative antibiotic therapy to reduce the level of acute inflammation.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 50 条
  • [1] Prognosis of Medication-Related Osteonecrosis of the Jaw with Surgical Treatment
    Kobayashi, Eizaburo
    Takahashi, Haruka
    Igarashi, Kensuke
    Katagiri, Hiroki
    Haga-Tsujimura, Maiko
    Ogura, Ichiro
    Nakahara, Ken
    Tanaka, Akira
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (01) : 39 - 46
  • [2] Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants
    Nisi, Marco
    Izzetti, Rossana
    Gennai, Stefano
    Bellini, Pierantonio
    Graziani, Filippo
    Gabriele, Mario
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (04) : 1037 - 1041
  • [3] Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings
    Kuniyasu Moridera
    Kazuhiro Kitajima
    Kyohei Yoshikawa
    Kazuki Takaoka
    Tatsuya Tsuchitani
    Kazuma Noguchi
    Hiromitsu Kishimoto
    Koichiro Yamakado
    Japanese Journal of Radiology, 2022, 40 : 492 - 499
  • [4] Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
    Favia, G.
    Tempesta, A.
    Limongelli, L.
    Crincoli, V.
    Maiorano, E.
    ORAL DISEASES, 2018, 24 (1-2) : 238 - 242
  • [5] Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study
    Choi, Na Rae
    Lee, Jung Han
    Park, Jin Young
    Hwang, Dae Seok
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (23) : 1 - 9
  • [6] Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings
    Moridera, Kuniyasu
    Kitajima, Kazuhiro
    Yoshikawa, Kyohei
    Takaoka, Kazuki
    Tsuchitani, Tatsuya
    Noguchi, Kazuma
    Kishimoto, Hiromitsu
    Yamakado, Koichiro
    JAPANESE JOURNAL OF RADIOLOGY, 2022, 40 (05) : 492 - 499
  • [7] Surgical resection and vascularized bone reconstruction in advanced stage medication-related osteonecrosis of the jaw
    Caldroney, S.
    Ghazali, N.
    Dyalram, D.
    Lubek, J. E.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 46 (07) : 871 - 876
  • [8] Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: An investigation of 206 patients undergoing surgical treatment
    Suyama, Koki
    Otsuru, Mitsunobu
    Nakamura, Norio
    Morishita, Kota
    Miyoshi, Taro
    Omori, Keisuke
    Miura, Kei-ichiro
    Soutome, Sakiko
    Hayashida, Saki
    Rokutanda, Satoshi
    Umeda, Masahiro
    JOURNAL OF DENTAL SCIENCES, 2024, 19 (03) : 1758 - 1769
  • [9] Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
    Hauer, Lukas
    Jambura, Jan
    Hrusak, Daniel
    Chalupova, Miroslava
    Posta, Petr
    Rusnak, Stepan
    Vyskocil, Vaclav
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (01): : 100 - 107
  • [10] Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response
    Kuniyasu Moridera
    Kazuhiro Kitajima
    Kyohei Yoshikawa
    Kazuki Takaoka
    Tatsuya Tsuchitani
    Kazuma Noguchi
    Hiromitsu Kishimoto
    Koichiro Yamakado
    Japanese Journal of Radiology, 2023, 41 : 760 - 767